Ladenburg Thalmann to Host Scientific Showcase on Rare Disease Clinical Development Efforts for Jaguar Health’s Crofelemer
Crofelemer Trials and Scientific Showcase Webinar Crofelemer Clinical Efforts Crofelemer is the subject of five clinical efforts – three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies – for the rare disease indications of microvillus inclusion disease (MVID) and/or short bowel syndrome with intestinal failure (SBS-IF) in the US, EU, and/or Middle East/North Africa…
